Autres langues Evaxion Biotech A/S

Actions

EVAX

US29970R2040

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
4,18 ^USD	+1,46%		-3,02%	-39,04%

26/04	Les actions européennes négociées aux États-Unis sous forme de certificats de dépôt américains sont en hausse vendredi et terminent la semaine en hausse de 3,4%.	MT
17/04	Evaxion annonce une mise à jour de l'essai clinique de phase 2	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	26/04
Evaxion Announces Phase 2 Clinical Trial Update	17/04
Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01	17/04
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	11/04
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	09/04
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading	08/04
Certain Warrants of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07/04
Certain American Depositary Shares of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07/04
Certain Ordinary Shares of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07/04
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	05/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading	03/04
ADRs End Lower; Meta Data Slides 22%	02/04
Sector Update: Health Care Stocks Slide Late Afternoon	02/04
Sector Update: Health Care Stocks Slipping in Afternoon Trading	02/04
Evaxion's EVX-B1 Vaccine Shows Promising Protection Against Staph Infections in Preclinical Studies; Shares Jump	02/04
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection	02/04
Evaxion and Undisclosed Collaborator Announce Encouraging Results for Evx-B1 Vaccine Antigens Against Staphylococcus Aureus Infection	02/04
16 APRIL 2024 AT 15:00 (CEST) - Form 6-K	29/03
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	28/03
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	27/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Evaxion Biotech A/S

Actions

EVAX

US29970R2040

Autres langues

Filtres